纤溶酶原激活物抑制剂-1与2型糖尿病被引量：1

下载PDF

导出

作者韩瑞红冯凭

机构地区天津医科大学总医院

出处《天津医药》 CAS 北大核心 2005年第11期742-744,共3页 Tianjin Medical Journal

关键词纤溶酶原激活物抑制物1 纤维蛋白溶解糖尿病 2型纤溶酶原激活物抑制剂-1 2型糖尿病血管内皮细胞纤溶系统活性新的危险因素慢性炎症炎性标志物

分类号 R541.4 [医药卫生—心血管疾病] R587.1 [医药卫生—内分泌]

引文网络
相关文献

参考文献20

1Hagglof P, Bergstrom F, Wilczynska M, et al. The reactive-center loop of active PAI-1 is folded close to the protein core and can be partially inserted .Mol Biol, 2004, 335(3): 823-832.
2Opatmy K Jr, Zemanova P, Mares J, et al. Fibrinolysis defect in long-term hemodialysis patients with type 2 diabetes mellitus and its relation to metabolic disorders. Am J Nephrol, 2002,22(5-6): 429-436.
3Leurs PB,Stolk RP,Hamulyak K,et al. Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes. Diabetes Care, 2002,25(8): 1340-1345.
4Stem MP.Diabetes and cardiovascular disease, the "common soil"hypothesis.Diabetes,1995,44(4):369-374.
5Festa A, D'Agostino R Jr, Tracy RP, et al. Elevated levels of acutephase proteins and plasminogen activator inhibitor- 1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes, 2002,51 (4): 1131-1137.
6Eliasson MC, Jansson JH, Lindahl B, et al. High levels of t-PA antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA Study. Cardiovasc Diabetol, 2003,2:19.
7He G, Bruun JM, Lihn AS, et al. Stimulation of PAI-1 and adipokines by glucose in human adipose tissue in vitro. Biochem Biophys Res Commun, 2003, 310(3): 878-883.
8彭怡文,宁光,李长贵,许曼音.NIDDM患者血浆纤溶酶原激活物抑制剂-1(PAI-1)与并发冠心病关系的探讨[J].中国慢性病预防与控制,1998,6(2):62-64. 被引量：9
9Sobel BE. Effects of glycemic control and other determinants on vascular disease in type 2 diabetes. Am J Med, 2002,113( Suppl ) 6A:12S-22S.
10Schneidennan J, Sawdey MS, Keeton MR, et al. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA, 1992,89:6996-7002.

二级参考文献7

1钱荣立.糖尿病肾病[A].见:王海燕.临床肾脏病学[C].北京:人民卫生出版社,1996.956.
2Juhan-Vague I, Roul C, AlessiMC, et al. Increased plasminogen activator inhibitor in noninsulin dependent diabetic patients: relationship with plasma insulin. Thromb Haemost, 1989, 61. 370.
3Hirano T, Kashiwazaki K, Moritomo Y, et al. Aluminuria is directly associated with increased Plasma PAI-1 and Factor Ⅻ levels in NIDDM patients. Diabetes Res Clin Pract, 1997,36:11-18.
4Magnatti P. Extracellular matrix remodeling by metalloproteinases and plasminogen activators. Kidney Int. 1995, 47 (suppl 49) : 12-14.
5GeigerM, BinderBR, Plasminogen activator in diabetes mellitus. Enzyme, 1995,40 :49.
6Katherin AH, Nancy MH, Peter CH, et al. Binding of tissue plasminogen activator to culture human endothelial cell. J Clin Invest,1987, 80:1712.
7Galajda P, Martinka E, Mokan M, et al. Endothelial markers in diabetes mellitus. Thromb Res, 1997,85 : 63-65.